The Bajpayee Lab represented Northeastern University at the 2026 OARSI World Congress (April 23–26 2026, West Palm Beach, FL) with three presentations advancing targeted musculoskeletal therapies. Dr. Ambika Bajpayee delivered a plenary talk on Advances in Cell-Specific Targeting Strategies for the Treatment of Osteoarthritis, sharing the lab’s foundational vision with the global research community. Bill Hakim delivered a podium talk on cationic IGF-1, a charge-based fusion protein designed for cartilage-targeted drug delivery in osteoarthritis. Helena Mary Baby presented a poster on avidin-mediated delivery of a RhoA activator for intervertebral disc degeneration, extending the lab’s charge-driven platform to a new clinical indication. The lab is proud of all three presenters for sharing their work with the global musculoskeletal research community.